Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters

Shazad Mushtaq, Marina Warner, David Livermore

Research output: Contribution to journalArticlepeer-review


We tested the activity of BAL30072, a novel siderophore monobactam, against multiresistant clinical isolates of Pseudomonas aeruginosa, Burkholderia cepacia group and Acinetobacter spp. and against laboratory P. aeruginosa strains with defined resistance mechanisms.
Original languageEnglish
Pages (from-to)266-270
Number of pages5
JournalJournal of Antimicrobial Chemotherapy
Issue number2
Publication statusPublished - Feb 2010


  • Acinetobacter
  • Anti-Bacterial Agents
  • Bacterial Proteins
  • Burkholderia cepacia complex
  • Drug Resistance, Multiple, Bacterial
  • Gram-Negative Bacterial Infections
  • Great Britain
  • Humans
  • Microbial Sensitivity Tests
  • Monobactams
  • Pseudomonas aeruginosa
  • beta-Lactamases

Cite this